Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Just Phase 2 results - 35 patients

<< Previous

Bullboard Posts

Next >>

Comment by Pandoraon May 25, 2022 2:44pm

185 Views

Post# 34707007

RE:RE:RE:Just Phase 2 results - 35 patients

Eoganacht wrote: Hi Pandora - I think the majority of the NR patients are the first 12 undertreated patients.

Thanks Eoganacht -- haven't noticed if that is a clarifying point that is included in the reports. We'll have to see how the next report comes out. In my opinion it would be a positive to clarify it as opposed to having people just see 37% NR.

<< Previous

Bullboard Posts

Next >>

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide